Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-26 to 2023-06-20
Current total value of award: $1338.52
Description: 4561152080!ZOLADEX 3.6 MG IMPLANT SYRNS